Premium
Role of the CYP2D6, EPHX1, MPO , and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children
Author(s) -
Silveira Vanessa da Silva,
Canalle Renata,
Scrideli Carlos Alberto,
Queiroz Rosane Gomes de Paula,
Tone Luiz Gonzaga
Publication year - 2010
Publication title -
environmental and molecular mutagenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 87
eISSN - 1098-2280
pISSN - 0893-6692
DOI - 10.1002/em.20510
Subject(s) - genotype , biology , myeloperoxidase , cyp2d6 , genetics , immunology , polymorphism (computer science) , haplotype , microsomal epoxide hydrolase , gene , epoxide hydrolase , in vitro , inflammation , microsome
Polymorphic variations of several genes associated with dietary effects and exposure to environmental carcinogens may influence susceptibility to leukemia development. The objective of the present study was to evaluate the effect of the polymorphisms of debrisoquine hydroxylase ( CYP2D6 ), epoxide hydrolase ( EPHX1), myeloperoxidase ( MPO ), and quinone‐oxoreductase ( NQO1 ), which have been implicated in xenobiotic metabolism, on the risk of childhood acute lymphoblastic leukemia (ALL). We evaluated the frequency of polymorphisms in the CYP2D6 (*3 and *4), EPHX1 (*2 and *3), MPO (*2), and NQO1 (*2) genes in 206 patients with childhood ALL and in 364 healthy individuals matched for age and gender from a Brazilian population separated by ethnicity (European ancestry and African ancestry), using the PCR‐RFLP method. The CYP2D6 polymorphism variants were associated with an increased risk of ALL. The EPHX1, NQO1, and MPO variant genotypes were significantly associated with a reduced risk of childhood ALL. A significantly stronger protective effect is observed when the EPHX1, NQO1 , and MPO variant genotypes are combined suggesting that, CYP2D6 polymorphisms may play a role in the susceptibility to pediatric ALL, whereas the EPHX1, NQO1 , and MPO polymorphisms might have a protective function against leukemogenesis. Environ. Mol. Mutagen., 2010. © 2009 Wiley‐Liss, Inc.